A combination of 1064 nm Q-switched fractional ND-YAG laser with a nonfractional microsecond pulsed technology has a synergistic effect for nonablative facial rejuvenation.


Journal

Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964

Informations de publication

Date de publication:
Aug 2021
Historique:
revised: 08 12 2020
received: 13 11 2020
accepted: 09 12 2020
pubmed: 29 12 2020
medline: 7 8 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Non-ablative fractionated lasers for facial rejuvenation are increasingly preferred over ablative lasers due to their minimal downtime and fewer adverse events. The synergistic effect of the Q-switched fractional (QSF) 1064-nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser, in combination with the non-fractional microsecond pulsed technology has yet to be fully evaluated. Our objective was to determine the safety and efficacy of this combination treatment for skin rejuvenation. Patients who underwent treatment using the QSF-Nd:YAG laser, followed by the non-fractional microsecond pulsed Nd:YAG were evaluated retrospectively using a novel 3D imaging modality for degree of facial erythema, wrinkles surface area, and wrinkle depth. Pain perception, adverse effects, and patient satisfaction were assessed at the 2-month post-treatment follow-up visit, graded on a scale of 1- 5 (1 = not satisfied, 5 = very satisfied). Ten female patients' ages 44-67 (mean 55 years) completed both treatment and follow-up period, with an overall mild improvement in facial erythema and wrinkle surface area (mean improvement of 18% and 19.5% accordingly), as well as a mild improvement in overall wrinkle depth. Pain and adverse effects were mild and transient. Patients' satisfaction was high. The combination of the QSF-Nd:YAG laser and non-fractional microsecond pulsed technology, using a single Nd:YAG 1064 nm laser platform, was found safe and effective as a non-ablative modality for facial rejuvenation, as demonstrated by a novel 3D imaging modality.

Sections du résumé

BACKGROUND BACKGROUND
Non-ablative fractionated lasers for facial rejuvenation are increasingly preferred over ablative lasers due to their minimal downtime and fewer adverse events. The synergistic effect of the Q-switched fractional (QSF) 1064-nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser, in combination with the non-fractional microsecond pulsed technology has yet to be fully evaluated.
AIM OBJECTIVE
Our objective was to determine the safety and efficacy of this combination treatment for skin rejuvenation.
METHODS METHODS
Patients who underwent treatment using the QSF-Nd:YAG laser, followed by the non-fractional microsecond pulsed Nd:YAG were evaluated retrospectively using a novel 3D imaging modality for degree of facial erythema, wrinkles surface area, and wrinkle depth. Pain perception, adverse effects, and patient satisfaction were assessed at the 2-month post-treatment follow-up visit, graded on a scale of 1- 5 (1 = not satisfied, 5 = very satisfied).
RESULTS RESULTS
Ten female patients' ages 44-67 (mean 55 years) completed both treatment and follow-up period, with an overall mild improvement in facial erythema and wrinkle surface area (mean improvement of 18% and 19.5% accordingly), as well as a mild improvement in overall wrinkle depth. Pain and adverse effects were mild and transient. Patients' satisfaction was high.
CONCLUSION CONCLUSIONS
The combination of the QSF-Nd:YAG laser and non-fractional microsecond pulsed technology, using a single Nd:YAG 1064 nm laser platform, was found safe and effective as a non-ablative modality for facial rejuvenation, as demonstrated by a novel 3D imaging modality.

Identifiants

pubmed: 33355995
doi: 10.1111/jocd.13912
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2515-2518

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Preissig J, Hamilton K, Markus R. Current laser resurfacing technologies: a review that delves beneath the surface. Semin Plast Surg. 2012;26:109-116.
Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: nonablative, fractional and ablative laser resurfacing. J Am Acad Dermatol. 2008;58:719-737.
Kaufman J.ND:YAG Laser Treatment of Vascular Lesions. Aesthet Dermatol. Basel, Karger, 2014, vol 1, pp 94-106.
Mi RR, Hye JC, Kee YC. Effects of various parameters of the 1064 nm Nd:YAG laser for the treatment of enlarged facial pores. J Dermatolog Treat. 2009;20:223-228.
Goldberg DJ, Silapunt S. Histologic evaluation of a Q-switched Nd:YAG laser in the nonablative treatment of wrinkles. Dermatologic Surg. 2001;27:744-746.
Urdiales-Gálvez F, Trelles MA, Martín-Sánchez S, Maiz-Jiménez M. Face and neck rejuvenation using an improved non-ablative fractional high power 1064-nm Q-switched Nd:YAG Laser: clinical results in 16 women. J Cosmet Laser Ther. 2020;22(2):70-76.
Luebberding S, Alexiades-Armenakas MR. Fractional non-ablative Q-switched 1064-nm neodimyum YAG laser to rejuvenate photoaged skin: a pilot study. J Drugs Dermatol. 2012;11:1300-1304.
Gold MH, Sensing W, Biron J. Fractional Q-switched 1064-nm laser for the treatment of photoaged-photodamaged skin. J Cosmet Laser Ther. 2014;16:69-76.
Schmults CD, Phelps R, Goldberg DJ. Nonablative facial remodeling: erythema reduction and histologic evidence of new collagen formation using a 300-microsecond 1064-nm Nd:YAG laser. Arch Dermatol. 2004;140:1373-1376.
Roh MR, Goo BC, Jung JY, Chung HJ, Chung KY. Treatment of enlarged pores with the quasi long-pulsed versus q-switched 1064 nm Nd: Yag lasers: a split-face, comparative, controlled study. Laser Ther. 2011;20:175-180.
Salameh F, Koren A, Sprecher E, Artzi O. Novel stereoscopic optical system for objectively measuring above-surface scar volume-first-time quantification of responses to various treatment modalities. Dermatol Surg. 2018;44(6):848-854.

Auteurs

Lehavit Akerman (L)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Moshe Lapidoth (M)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Laser Unit, Division of Dermatology, Rabin Medical Center, Petah-Tiqva, Israel.

Assi Levi (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Laser Unit, Division of Dermatology, Rabin Medical Center, Petah-Tiqva, Israel.

Eran Sharon (E)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Surgery, Breast Surgery Clinic, Rabin Medical Center, Petah-Tiqva, Israel.

Daniel Hilewitz (D)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Efrat Solomon-Cohen (E)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Laser Unit, Division of Dermatology, Rabin Medical Center, Petah-Tiqva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH